Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youngjin Han

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Journal of Ovarian Research|June 6, 2022
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancersBao Kong, Chae Young Han, Se Ik Kim, et al.
Frontiers in Oncology|June 1, 2022
Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian CancerWenyu Wang, Untack Cho, Anna Yoo, et al.
EJNMMI Research|January 9, 2019
A phase 1, first-in-human study of <sup>18</sup>F-GP1 positron emission tomography for imaging acute arterial thrombosisSun Young Chae, Tae-Won Kwon, Soyoung Jin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2018
Glycoprotein IIb/IIIa receptor imaging with <sup>18</sup>F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 studyChanwoo Kim, Jae Seung Lee, Youngjin Han, et al.
Cancers|July 24, 2021
Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian CancerChae Young Han, David A Patten, Se Ik Kim, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Journal of Ovarian Research|June 6, 2022
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancersBao Kong, Chae Young Han, Se Ik Kim, et al.
Frontiers in Oncology|June 1, 2022
Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian CancerWenyu Wang, Untack Cho, Anna Yoo, et al.
EJNMMI Research|January 9, 2019
A phase 1, first-in-human study of <sup>18</sup>F-GP1 positron emission tomography for imaging acute arterial thrombosisSun Young Chae, Tae-Won Kwon, Soyoung Jin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2018
Glycoprotein IIb/IIIa receptor imaging with <sup>18</sup>F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 studyChanwoo Kim, Jae Seung Lee, Youngjin Han, et al.
Cancers|July 24, 2021
Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian CancerChae Young Han, David A Patten, Se Ik Kim, et al.
Pageof 11